To determine sensitivity and specificity of ultrasound (US) findings for gout: "double contours" (DC) and hyperechogenic aggregates (HAGs) of symptomatic and asymptomatic joints in patients with gout. Methods: This prospective study included 69 persons (34 patients with primary gout and 35 healthy subjects). Including criteria for patients with gout were: age ≥18 years; diagnosis of primary gout; absence of acute gout attacks during the study tests; the absence of any other inflammatory and infectious joint disease, and secondary gout. The research included: demography and medical history. Physical and US examination covered following structures: 138 radiocarpal joint, 276 patellar and triceps tendon and 414 articular cartilages (first metatarsal, talar and femoral condyle). Results: Both groups were compatible for age and gender. In the gout group 124 (30%) symptomatic and 284 (70%) asymptomatic joints were found and in healty group all joints was asymptomatic. The sensitivity of the DC for symptomatic joint was 56 to 84% and specificity also was very high 91 to 94% as well as positive and negative predictive value (69 -86% and 38 -71%). Sensitivity of DC finding for the asymptomatic joints was 42 to 73% and specificity was 91 to 94%, with also high positive and negative predictive value (69 -89% and 44 -62%). The specificity of the HAGs for both symptomatic and asymptomatic joints was very high 99% but sensitivity of HAGs symptomatic structures was moderate (41 do 56%), while its sensitivity for asymptomatic structures was low (18 to 34%), table 1. Conclusions: Ultrasound examination of symptomatic and asymptomatic joints in patients with gout equally observed structural changes characteristic of gout. The finding of "double contours" in the symptomatic and asymptomatic joints has a very high sensitivity and specificity. Consequently, future research should be focused on the ultrasound examination of asymptomatic joints in patients with gout.
Conclusions: Ultrasound examination of symptomatic and asymptomatic joints in patients with gout equally observed structural changes characteristic of gout. The finding of "double contours" in the symptomatic and asymptomatic joints has a very high sensitivity and specificity. Consequently, future research should be focused on the ultrasound examination of asymptomatic joints in patients with gout. However, no statistically significant changes in cartilage quality were found after KJD or HTO, not in the medial and lateral compartments of the tibiofemoral joint, nor in the separate ROIs (see figure 1) .
Conclusions:
Treatment of medial compartmental OA by either HTO or KJD leads to alleviation of pain and recovery of function, achieved one year after either intervention, and maintained for another year. Within the first year after treatment, KJD shows a statistically significantly higher increase in WOMAC as compared to HTO. Both treatments led to a statistically significant increase in JSW after one and two years, postponing the natural osteoarthritis progression rate. No statistically significant change in the quality of newly formed cartilaginous tissue could be detected by dGEMRIC. Background: Imaging arthritis activity in rheumatoid arthritis (RA) patients using PET macrophage tracers holds promise for both early diagnostics and monitoring response to therapy (1,2). Previously, (R)-[
11 C]PK11195 has been used, but this macrophage tracer is limited due to high background uptake, especially in bone and bone marrow. Recently, a novel macrophage tracer, [
18 F]fluoro-PEG-folate,
